 |
Release Date: Tuesday, October 13, 2020 Educational Needs Multidrug-resistant (MDR) Gram-negative bacteria are associated with substantial clinical and economic burden and continue to challenge clinicians in the acute care setting. For serious bacterial infections, such as hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), initial appropriate antimicrobial therapy is essential for favorable patient outcomes. Fortunately, several new and novel antimicrobials have been approved for the treatment of HABP/VABP that offer clinicians viable options to manage critically ill patients in a pathogen-specific manner. Optimized use of these agents requires a thorough understanding of their pharmacotherapeutic potential to fully realize their role in the clinical setting. This activity provides a detailed overview of new and novel antimicrobials approved for the treatment of HABP/VABP to empower clinicians to make informed decisions on the use of these agents when treating MDR Gram-negative infections. Learning Objectives At the conclusion of the educational activity, the learner should be able to:
Target Audience: This continuing medical education activity is planned to meet the needs of ID healthcare providers, including physicians, pharmacists, and microbiologists, in a variety of practice settings, including large and small health systems, outpatient clinics, managed-care organizations, long-term care facilities, and academia. |
Faculty
Educational Format As part of the overall educational initiative, this pre-activity webinar provides a detailed overview of new and novel antimicrobials approved for the treatment of HABP/VABP that target MDR Gram-negative pathogens. In preparation for the live IDWeek symposium, we encourage you to view this pre-activity webinar to broaden the understanding of key aspects of each of these agents, including spectrum of activity, pharmacokinetic/pharmacodynamic profile, and early efficacy and safety results. The live IDWeek symposium will build on this knowledge and discuss the clinical application of these agents when managing patients with HABP/VABP. The pre-activity webinar includes the following sections:
|
|
Accreditation Physicians Physician Assistants Nurse Practitioners Pharmacists For questions regarding the accreditation of this activity, please contact us at info@jointsponsor.com
Method of Participation and Instruction for Credit
Disclosure of Conflicts of Interest In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.
|
Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer. Disclosures
No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. Fee Hardware/Software Requirements Software/Hardware Connection Speed System Check Copyright Statement Privacy Policy http://www.vemcomeded.com/privacy.aspJoint Providership Commercial Support This activity is supported by an educational grant from Merck & Co., Inc.
|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.
|
|
